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Production of butyrate from lysine and the Amadori
product fructoselysine by a human gut commensal
Thi Phuong Nam Bui1, Jarmo Ritari2, Sjef Boeren3, Pieter de Waard4, Caroline M. Plugge1 & Willem M. de Vos1,2,5
Human intestinal bacteria produce butyrate, which has signalling properties and can be used
as energy source by enterocytes thus inﬂuencing colonic health. However, the pathways
and the identity of bacteria involved in this process remain unclear. Here we describe the
isolation from the human intestine of Intestinimonas strain AF211, a bacterium that can convert
lysine stoichiometrically into butyrate and acetate when grown in a synthetic medium.
Intestinimonas AF211 also converts the Amadori product fructoselysine, which is abundantly
formed in heated foods via the Maillard reaction, into butyrate. The butyrogenic pathway
includes a speciﬁc CoA transferase that is overproduced during growth on lysine. Bacteria
related to Intestinimonas AF211 as well as the genetic coding capacity for fructoselysine
conversion are abundantly present in colonic samples from some healthy human subjects.
Our results indicate that protein can serve as a source of butyrate in the human colon, and its
conversion by Intestinimonas AF211 and related butyrogens may protect the host from the
undesired side effects of Amadori reaction products.
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O
ur intestinal tract contains trillions of microbes that
impact our health1. The metabolic capacity of these
microbes is enormous2 and includes the production of
short-chain fatty acids, such as butyrate that serves as a major
source of energy for the intestinal enterocytes and signals to the
host3. Butyrogenic gut bacteria belong to Lachnospiraceae
and Ruminococcaceae4, and recent studies showed an inverse
correlation between these butyrogenic Firmicutes and
inﬂammatory bowel disease, type 2 diabetes and various other
disorders5,6. Moreover, there is considerable interest in these
butyrogens, since butyrate reduces proinﬂammatory signals3 and
has a protective role in maintaining a healthy colon7,8. Thus, it is
of paramount importance to identify the microbes that are
capable of producing butyrate and understand the mechanisms
underlying its production.
Most butyrate produced in the human intestine is assumed
to derive from carbohydrates, while some specialized
bacteria have been found that convert lactate plus acetate
into butyrate9,10. All of these produce butyrate via the
acetyl-CoA pathway11 (converting acetyl-CoA to butyrate)
that involves a complex cascade of reactions, in which
butyrate CoA transferase (But) or butyrate kinase (Buk) are
key enzymes. In a recent (meta)genome-based study, it was
predicted that the But-mediated route was 10-fold more
abundant than that mediated by Buk, while these two enzymes
showed high diversity among butyrogens12. Three other routes
for butyrate synthesis, the glutamate, succinate and lysine
pathways, have been described. On the basis of the distribution
of the genes in the intestinal metagenome libraries, the acetyl-
CoA pathway was the most prevalent followed by the lysine
pathway. Yet, no intestinal bacterium has been reported
that contained all genes coding for butyrogenesis from this
amino acid13.
In addition to carbohydrates, proteins are crucial dietary
compounds that are receiving increased attention to their use in
special diets. Proteolytic enzymes in the upper intestinal tract
generate amino acids that are rapidly taken up by the host, but
also may reach the colon, partly depending on the intake.
Moreover, protein recycling in the colon has been described,
adding to the interest in colonic amino-acid fermentations.
Amadori products (fructosamines), formed via non-enzymatic
reactions between reducing sugars and free amino groups of
proteins during the food heating process, are of signiﬁcant
interest as they have shown to be associated with the ageing
process and several chronic diseases14. Fructoselysine is a key
intermediate in the formation of advanced glycation
endproducts (AGEs)14 and not yet any organism has been
known to convert fructoselysine into butyrate. Only a few
microbes have been reported to metabolize lysine into butyrate,
and they derive from ecosystems other than the gut. A lysine
degradation pathway was described over 50 years ago in
Clostridium sticklandii isolated from black mud15. More
recently, this pathway was detected in Clostridium
subterminale SB4 isolated from sewage and Fusobacterium
nucleatum isolated from the oral cavity, and eight genes
encoding a lysine fermentation pathway were identiﬁed from
the genome of F. nucleatum16. Several enzymes involved in
butyrogenesis from lysine have been biochemically
characterized17–20, but so far no intestinal microorganism has
been found to contain the entire pathway in spite of the
predicted presence of the lysine fermentation pathway in the
human intestine13,16–18. Here we describe the butyrogenic
conversion of lysine and the Amadori product fructoselysine
by a novel Intestinimonas strain from a healthy volunteer and
characterize its butyrate synthesis pathway by using a combined
physiological, biochemical and proteogenomic approach.
Results
Lysine degradation by Intestinimonas AF211. In a search
for new butyrogens, strain AF211 was isolated from the stool
of a healthy subject using a mineral bicarbonate-buffered medium
with lactate and acetate, under strict anoxic conditions (butyrate
was found as the main end product). Strain AF211 contained
two copies of the 16S rRNA gene that differed in a single
nucleotide, and subsequent phylogenetic analysis showed that this
strain belonged to clostridial cluster IV (Lachnospiraceae) of
the Firmicutes phylum. Further analysis showed that this 16S
rRNA sequence was highly similar to that of the mouse intestinal
isolate Intestinimonas butyriciproducens DSM26588T (ref. 21),
indicating that the newly isolated strain AF211 belongs to the
genus Intestinimonas (Supplementary Fig. 1). However,
strain Intestinimonas AF211 was a human isolate and showed
physiological differences with I. butyriciproducens from mouse
(to be reported elsewhere). Butyrate was found to be a major
metabolite from all substrates where growth was observed
(Supplementary Table 1). Intestinimonas AF211 hardly grew on
glucose in mineral medium (generation time of 88 days), but its
growth rate tripled in the presence of acetate and yeast extract. In
media containing 20mM glucose with 20mM acetate and 2%
yeast extract, Intestinimonas AF211 produced up to 4.4mM
butyrate and trace amounts of lactate and ethanol (2-week
incubation). Remarkably, the strain grew much better (generation
time of 7.5 h) in L-lysine but not in any other natural amino acids
or D-lysine (Supplementary Table 1).
To study the capacity to convert lysine into butyrate,
Intestinimonas AF211 was grown in bicarbonate-buffered
medium containing L-lysine as the sole carbon and energy
source. A total of 16.8±0.4mM lysine was converted into
14.2±0.6mM butyrate, 15.6±0.7mM acetate and 22.1±0.5mM
NH3 when the cells reached the stationary phase after 2 days
at 37 C (Fig. 1a). This suggests that part of the released
ammonia is sequestered into proteins during anabolism of
Intestinimonas AF211. Hence, we propose the fermentation
reaction as: C6H14O2N2þ 2H2O-C4H8O2þC2H4O2þ 2NH3.
Clearly, Intestinimonas AF211 is capable of growing in deﬁned
media with L-lysine as sole carbon and energy source with a
maximum growth rate of 0.1 h 1.
Growth of Intestinimonas AF211 on fructoselysine. As fructo-
selysine is a key intermediate in the formation of AGEs, we
addressed its degradation by Intestinimonas AF211 and found it
to be readily metabolized (Fig. 1b; generation time 24 h). Butyrate,
NH3 and lactate were formed as the main products. The
conversion equation is proposed as: C12H24O7N2þ 2 H2O-2
C4H8O2þ 2 NH3þ 1 CO2þ 1 C3H6O3. We anticipate that the
fructoselysine pathway includes the simultaneous degradation of
both lysine and the sugar moiety in two branches (termed lysine
pathway and acetyl-CoA pathway; Fig. 2). Some deviations in the
butyrate/fructoselysine ratio were observed (Supplementary
Tables 1 and 2). These may be attributed to the different envir-
onmental conditions but also be caused by the intracellular
balance between the two branches of the fructoselysine pathway
(Fig. 2). However, the initial concentration of acetate was pre-
dicted to be a major factor affecting the butyrate/fructoselysine
ratio. We experimentally veriﬁed this and observed that in the
presence of extra acetate, fructoselysine was completely converted
into butyrate and NH3 (Supplementary Table 2) according to
the equation: C12H24O7N2þC2H4O2þH2O-3 C4H8O2þ 2
NH3þ 2 CO2. The growth rate in fructoselysine plus acetate was
signiﬁcantly higher than that in fructoselysine alone
(Supplementary Table 2), which could be due to stimulation of
butyrate production via external acetate, leading to an increased
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energy gain by generating a proton motive force via the
membrane-associated Rnf complex and consequently, no extra
NADH needed for lactate formation (Fig. 2). The inﬂuence of
acetate on the growth of fructoselysine resembles the human gut
environment where acetate is abundantly present11. Previously,
the conversion of fructoselysine has been reported for a few
bacteria, including Escherichia coli, which also converts
psicoselysine22,23. However, none of these bacteria are capable
of butyrogenesis. To provide further support for the butyrogenic
pathway we focused on lysine and glucose degradation by using a
combined approach of nuclear magnetic resonance (NMR),
proteogenome and enzyme activity assays.
Elucidation of the lysine degradation pathway using 13C-NMR.
To elucidate the butyrogenic pathway of Intestinimonas AF211,
we applied in vivo 1H-decoupled 13C-NMR analysis of the culture
supernatants of cells grown with L-[2-13C]lysine, L-[6-13C]lysine
and lysine plus [2-13C]acetate as described previously24. Growth
of Intestinimonas AF211 on L-[6-13C]lysine resulted in its
complete conversion into [4-13C]butyrate, [2-13C]acetate,
[2-13C]butyrate and [2,4-13C]butyrate (Fig. 3a, left). Proton-
detected multiple-bond spectroscopy was also performed with the
supernatant and based on the Heteronuclear Multiple-Bond
Correlations (HMBCs) we could estimate the percentages of
[4-13C]butyrate, [2-13C]butyrate and [2,4-13C]butyrate out of all
labelled butyrate (Fig. 3b, left). Combination of this quantitative
and kinetic analysis showed that at all time points the main
product formed from L-[6-13C]lysine was [4-13C]butyrate (71%;
Fig. 3c), indicating that cleavage of lysine occurred between the
C2 and C3 residues. Both [4-13C]butyrate, [2-13C]butyrate and
[2,4-13C]butyrate were detected in the cells grown in lysine plus
[2-13C]acetate (Fig. 3a,b, right). This is indicative of simultaneous
operation of the acetyl-CoA and lysine degradation pathways
(Fig. 2) and explained the formation of minor amounts
of [2-13C]acetate, [2-13C]butyrate and [2,4-13C]butyrate in L-[6-
13C]lysine. Altogether, these data provide molecular evidence that
the lysine pathway was substantially active and generated the
intermediates for the acetyl-CoA pathway in Intestinimonas
AF211. Similar results supporting the simultaneous operation
of the two pathways were obtained by using D,L-[2-13C]lysine
in growing cells of Intestinimonas AF211, and the NMR
analysis also conﬁrmed the exclusive selectivity for L-lysine
(Supplementary Fig. 2). High-performance liquid chromato-
graphy (HPLC) analysis conﬁrmed the nearly complete
conversion of lysine to equimolar amounts of butyrate and
acetate as indicated above (Fig. 1a). The molecular events
that explain the observed isotopomers derived from [13C]lysine
were reconstructed (Supplementary Fig. 3) and the deduced
metabolic pathway revealed 10 enzymatic reactions that
were further characterized by genomic, proteomic and enzyme
studies (Fig. 2).
Proteogenomic analysis of the metabolic pathways. The
complete genome of Intestinimonas AF211 was determined using
single-molecule next-generation sequencing revealing a circular
chromosome of 3,376,476 bp, predicted to encode 3,359 genes
(NCBI accession number CP011307; to be reported elsewhere).
Gene candidates for the fructoselysine and lysine metabolic
pathways and linked energy-generating conversions were identi-
ﬁed in the annotated genome of Intestinimonas AF211 (Fig. 2 and
Supplementary Fig. 4). These included an operon-like cluster
(AF_00949-00955) with genes for fructoselysine and psicoselysine
uptake and degradation14 and a lysine utilization operon
(AF_00976-00982) coding for six key enzymes involved in
converting lysine into butyrate (Supplementary Fig. 4).
To conﬁrm the presence and gene expression of the lysine
degradation pathway in Intestinimonas AF211, proteins extracted
from cells grown on either lysine or glucose and acetate were
analysed by semi-quantitative proteomics (Supplementary Fig. 4
and Supplementary Data 1). Intestinimonas AF211 was found to
produce all proteins involved in the conversion of glucose and
acetate into butyrate and employed the acetyl-CoA pathway,
similar to other members of Ruminococcaceae and Lachnospir-
aceae8. Moreover, the proteins involved in the lysine pathway
(encoded by the cluster AF_00976-00982) were not only highly
abundant but also differentially and B10-fold induced during
growth on lysine compared with glucose and acetate, except for
3-aminobutyryl-CoA ammonia-lyase (encoded by AF_00976),
which was not detected. The latter protein is rather small
(14 kDa) and may have been lost during the protein extraction.
Another annotated Kce candidate (AF_02981) was found to be
reduced 10-fold during the growth in lysine and is present in very
low level, pointing to another function rather than being involved
in the lysine pathway. Two predicted 3-ketoacyl-CoA thiolases
(AF_03338 and AF_00601) were 1.3-fold and 1.8-fold more
abundant in lysine-grown cells than glucose and acetate-grown
cells. AF_03338 is located in the same gene cluster operon with
AtoD-A (AF_03339-03340; see below), which is a lysine-
inducible key enzyme in the lysine pathway19. Thus, AF_03338
is likely to be co-expressed under lysine growth conditions, while
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Figure 1 | L-lysine and fructoselysine conversion by strain Intestinimonas AF211 throughout time. Carbon recovery was 87% and 101% for the lysine (a)
and fructoselysine (b) utilization, respectively. Exact concentrations of substrates and products and optical density values are included in Supplementary
Table 1. Values are mean of biological duplicates. Error bars indicate s.d.
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the product of AF601 might participate in the simultaneous
conversion of acetate into butyrate. Several predicted butyryl-
CoA dehydrogenase (bcd) genes were detected in the genome but
only one of these (AF_02889) formed an operon-like cluster with
the Etf complex genes25 (AF_02890-02891). The reactions
catalysed by ferredoxin oxidoreductase plus the exergonic
NADH-dependent reduction of crotonyl-CoA to butyryl-CoA
show a possible chemi-osmotic energy conservation via the Rnf
complex26. This is essential under all growth conditions and
hence the proteins encoded by this gene cluster were always
detected (Fig. 2). The phosphate transacetylase (AF_00212) and
acetate kinase (AF_01052) were found to be induced B3-fold in
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that is subsequently cleaved by fructoseamine deglycase (AF_00951) into lysine and glucose-6-phosphate (indicated by the purple arrows). Lysine is then
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one butyrate through the lysine pathway), while no lactate is produced; however, when no exogenous acetate is present, fructoselysine is converted into
approximately two butyrate and one lactate (see Supplementary Table 2 for details).
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lysine-grown cells compared with glucose and acetate-grown
cells, indicative of the involvement of these two enzymes in the
lysine pathway. Remarkably, proteome analysis revealed the
fructoselysine operon-like genes to be induced up to 25-fold
during growth on lysine (Supplementary Fig. 4 and
Supplementary Data 1), most likely due to a high amount of
lysine, which was also an intermediate in the fructoselysine
pathway (Fig. 2).
Phylogeny of CoA transferases and enzyme activity. A crucial
reaction involved in butyrate formation from lysine is the transfer
of a CoA moiety from one molecule to another, catalysed by
members of the CoA transferase family. Remarkably, analysis of
the genome of Intestinimonas AF211 predicted the presence of
14 such enzymes, and a phylogenetic tree was generated based
on these and CoA transferases from intestinal bacteria and
environmental isolates (Fig. 4a). These include the CoA
transferases AtoD-A, 4Hbt and But, for which experimental
evidence for their involvement in butyrate synthesis has been
described in several anaerobes, including Clostridium SB4,
Roseburia spp., Faecalibacterium prausnitzii and Clostridum
acetobutylicum8,19,27. Five well-separated clades of enzymes could
be distinguished. One clade included the But enzymes from the
main butyrate producers in the human intestine, belonging to the
Lachnospiraceae, and Ruminococcaceae4 that are all capable of
butyrogenesis from glucose or lactate plus acetate8,28. The
Intestinimonas AF211 enzyme encoded by AF_02986 belonged
to this But clade and was detected in the proteome under
both growth conditions, indicating that it participated in the
acetyl-CoA pathway rather than 4-aminobutyrate or glutamate
pathways. The second clade harboured the 4Hbt enzymes and
included several predicted CoA transferases of Intestinimonas
AF211 but none was detected at the protein level. The third and
fourth clades held the a and b subunits of the AtoD-A enzymes,
respectively, that are encoded by two juxtaposed genes in
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the well-studied anaerobes: F. nucleatum, C. sticklandii and
C. acetobutylicum29–33. Within these two AtoD-A subunit clades,
three gene pairs of Intestinimonas AF211 were clustered.
However, only one of these, encoded by AF_03339-03340, was
highly abundant and induced two-fold under lysine growth
conditions, indicative of its involvement in butyrate formation
via the lysine pathway (Fig. 2). A ﬁfth cluster of acetyl-
CoA:acetoacetate CoA transferases (AtoC) contained enzymes
not only from Intestinimonas AF211 (indicated by AF_00155,
AF_02540 and AF_01396) but also from Anaerostipes
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Figure 4 | Phylogeny of CoA transferase and enzyme activity. (a) Phylogenetic tree of predicted CoA transferases from Intestinimonas AF211 (bold) and
other representative anaerobes. The tree was based on sequences from butyryl-CoA:acetate CoA transferase (But, in blue), butyryl-CoA:4-hydroxybutyrate
CoA transferase (4Hbt, in purple), butyryl-CoA:acetoacetate CoA transferase (Ato) alpha subunit (AtoD, in orange), beta subunit (AtoA, in brown) and
acetyl-CoA:acetoacetate CoA transferase (AtoC, in green), respectively. Green dots indicate non-intestinal isolates. Intestinimonas AF211 proteins induced
during growth on lysine are indicated by the red arrows. (b) Butyryl-CoA:acetoacetate CoA transferase activity in crude cell extracts. Each measurement
was performed with biological duplicates and 4–6 replicate measurements. Values represent mean of replicates. Error bars indicate s.d.’s. Green and red
bars represent the enzyme activity of Intestinimonas AF211 grown in lysine and glucose plus acetate, respectively; blue bar is the negative control with A.
rhamnosivorans DSM26241 grown on glucose, which is not capable of lysine fermentation.
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rhamnosivorans, which is capable of butyrogenesis from glucose
as well as from acetate plus lactate34. The four-fold protein
induction of AtoC (AF_00155) during growth on lysine indicated
the involvement of this CoA transferase in lysine degradation.
We propose its role to be the balancing of acetyl-CoA, released
from the acetyl-CoA pathway and providing either additional
acetoacetate or acetoacetyl-CoA, in line with the simultaneous
activity of the lysine and acetyl-CoA pathway during
butyrogenesis from lysine (see above).
To further provide support for the pivotal conversion catalysed
by AtoD-A, its activity in Intestinimonas AF211 was studied by
incubating cell-free extracts under anaerobic conditions with
acetoacetate and butyryl-CoA, and monitoring the production of
acetoacetyl-CoA19,30. We found reproducible and high activity of
this enzyme activity in cells grown on lysine (237 units per mg
protein), which was 3.5-fold reduced in cells grown with glucose
and acetate (71 units per mg protein; Fig. 4b). As the observed
activity induction coincided with the protein quantitation from
the proteome analysis, we deduce that AtoD-A (encoded by
AF_03339-03340) is probably the butyryl-CoA:acetoacetate CoA
transferase involved in the butyrogenic lysine pathway.
Intestinimonas and fructoselysine genes in the human gut. As
metagenome analysis indicated that the lysine pathway has high
abundance in the human intestine13, we studied the presence of
Intestinimonas related to AF211 in a series of healthy subjects by
using a speciﬁc 16S rRNA-based quantitative PCR (qPCR)
(Supplementary Table 3). In 5 out of 10 subjects, 0.2–10% of
the 16S rRNA sequences were derived from Intestinimonas spp.
since all qPCR products showed the expected nucleotide
sequence. From faecal DNA of the remaining ﬁve subjects,
amplicons were generated, but sequence analysis showed four of
them to derive from Ruminococcus spp. as their 16S rRNAs
fortuitously ampliﬁed with the used primers, indicating it is not
possible to correctly estimate the level of Intestinimonas spp. in
these subjects (Supplementary Table 3). When analysing the deep
metagenome information obtained in 65 subjects characterized in
the Human Microbiome Project35, we could identify many of the
genes for lysine degradation in over half of the subjects
but the genes involved in fructoselysine degradation were only
observed in half a dozen individuals as indicated by the presence
of the key gene fructoselysine kinase (Supplementary Fig. 5).
The observed abundance and prevalence of Intestinimonas spp.
level is in good agreement with the metagenome-predicted
presence of the lysine degradation pathway13, suggesting that
Intestinimonas is the key species converting lysine and
fructoselysine into butyrate in the human gut. This is supported
by the recent isolation of a similar but antibiotic-resistant strain
from a healthy subject36. However, it is evident that not all
humans have intestinal metagenomes that are equipped with
genes for the conversion of fructoselysine, the major Amadori
product.
Discussion
Here we describe the isolation of a butyrate-producing bacterium,
Intestinimonas AF211, abundantly present in the intestine of
some humans. The bacterium can use fructoselysine, a key
intermediate in the formation of AGEs, as sole carbon and energy
source by converting this into mainly butyrate and NH3. The
predicted fructoselysine pathway includes the simultaneous
degradation of both lysine and sugar moiety. By determining
the metabolic route of the 13C-labelled lysine conversion by
NMR, in combination with enzyme measurements and proteo-
genomic analysis, the butyrogenic pathway from lysine was fully
elucidated and also indicated the presence of the fructoselysine
pathway in Intestinimonas AF211. The use of fructoselysine as
carbon and energy source for butyrogenesis is unique, and
Intestinimonas AF211 is the ﬁrst intestinal bacterium to harbour
the complete pathway for the conversion of lysine into butyrate
(Fig. 1), previously predicted based on metagenomic data13.
Lysine is an essential amino acid that is cleaved from dietary
proteins by pancreatic trypsin, producing peptide chains with a
C-terminal arginine or lysine residue37, The generated lysine-
containing peptides can be utilized via the proteolytic activity of
Intestinimonas AF211 as evidenced by its growth on different
protein-derived substrates (Supplementary Table 4) and the
several-fold induction of various aminopeptidases under lysine
growth condition (Supplementary Table 5). Collectively, one can
consider the butyrogenic conversion of lysine by Intestinimonas
AF211 as a speciﬁc example of host–microbe interactions.
Degradation of L-lysine was previously observed in complex
media by F. nucleatum, suggesting that this Gram-negative
bacterium and potential pathogen can use L-lysine as energy
source but its use as carbon source is not clear16,32,38.
C. sticklandii uses L-lysine as an electron donor in the Stickland
reaction and lysine was only degraded in the stationary phase
when other amino acids were depleted29. Despite the fact that a
few bacteria have been reported to degrade lysine to butyrate,
recent (meta) genomic analysis, which included genomes from
these isolates, indicated that none of the genomes analysed had
genes for the entire pathway13. In addition, E. coli and Bacillus
subtilis were found to be capable of degrading fructoselysine but
none of them produces butyrate14. However, Intestinimonas
AF211 contained all genes involved in degradation of
fructoselysine to butyrate (Fig. 2) while proteomic analysis
revealed that these genes were induced under the lysine growth
conditions.
Remarkably and unlike other butyrogenic bacteria,
Intestinimonas AF211 was found to contain over a dozen genes
coding for CoA transferases (Fig. 4a). We hypothesize that this
may help the bacterium to be more ﬂexible to act on a broad
range of substrates. The integrated analysis of the Intestinimonas
AF211 genome, proteome and activity measurements
revealed that a speciﬁc acetoacetyl-CoA transferase AtoD-A
(AF_03339-03340) was abundantly expressed under lysine
degradation conditions and hence predicted to be the key enzyme
involved in butyrate synthesis. As this is the ﬁrst described lysine
pathway in the intestinal ecosystem, the lysine utilization operon
and the identiﬁed AtoD-A genes may have application as markers
for butyrogenesis from lysine.
An important corollary of the abundant presence of
lysine-degrading butyrogenic Intestinimonas AF211 and relatives
in the intestine of some humans is the fact that amino acids can
serve as source of butyrate formation. Since butyrate has
presumed health beneﬁts as an energy source for colonocytes
and is a vital molecule to maintain intestinal integrity, this may
nuance suggestions that protein fermentation, notably in the
distal colon, has a negative health impact39. Remarkably, we
observed that Intestinimonas AF211 is also capable of growth on
fructoselysine as sole carbon and energy source resulting in the
conversion of fructoselysine into butyrate (Supplementary
Table 1). The Amadori product fructoselysine is abundant in
cooked foods and is formed via the non-enzymatic Maillard
reaction of reducing sugars and amino acids during the heating
process. As humans are unique in the consumption of cooked
products at a large scale, it would be of interest to determine
whether the fructoselysine gene cluster detected in Intestinimonas
AF211 has been recently acquired and is not present in the gut
microbes of other primates. The production of fructoselysine
from cooked foods has various impacts, including the loss of
essential amino acids and a reduced protein digestibility.
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Fructoselysine is key product leading to the formation of AGEs in
the human body that have been associated with chronic diseases
and development of diabetes complication40–42. Moreover, recent
food interventions in mice showed the deleterious effect of AGEs
on these and other diseases43. The butyrogenic conversion of
fructoselysine by Intestinimonas AF211 illustrates the important
role of this anaerobe in the human intestinal tract, whereas the
observation that some but not all human carry genes for
fructoselysine degradation indicates the potential for speciﬁc
interventions with the newly discovered strain. In conclusion, our
study underlines the need for cultivating novel microbes to get a
comprehensive understanding of the intestinal metabolic
processes and the beneﬁcial effect on the human host. In
addition, Intestinimonas AF211 and related bacteria may play an
important role in the intestinal tract by maintaining protein
balance and gut homeostasis.
Methods
Enrichment, isolation and growth. Strain Intestinimonas AF211 was isolated
from the stool of a healthy adult. The faecal sample was enriched in an anaerobic
bicarbonate-buffered mineral salt medium44 containing 40mM lactate and 40mM
acetate as energy and carbon source. The head space was ﬁlled with CO2/N2 (1:4) at
1.5 atm and incubation was at 37 C. Subsequently, the enrichment culture was
transferred to reinforced clostridium medium (RCM, Difco) in serial dilutions and
plated at least three times on RCM agar, which resulted in an axenic culture. The
purity of the strain, designated as strain AF211, was conﬁrmed by 16S rRNA gene
sequencing and microscopy. The strain was routinely maintained in RCM medium
at 37 C. A phylogenetic tree of the 16S rRNA of Intestinimonas AF211 (GenBank
accession JX273469) and closely related strains was constructed as described
previously34 (Supplementary Fig. 1).
For physiological characterization, different amino acids and amino-acid
derivatives were tested including 20mM of L-lysine, fructoselysine (USBiological,
USA), glutamate, glutamine, glycine, proline, arginine, aspartate and methionine,
which were added into the bicarbonate-buffered medium from 1M sterile anoxic
stock solutions. For sugar utilization 20mM glucose plus 20mM acetate were
added into the bicarbonate-buffered medium from 1M stock solutions. The growth
was determined via product formation by HPLC34 and optical density
measurement by a spectrophotometer at a wavelength of 600 nm. Generation times
were calculated employing Gompertz modelling45.
Analytical methods. Lysine was quantiﬁed on a HPLC using a Polaris C18-A
column (Agilent) running at 45 C and an ultraviolet–visible detector at wavelength
of 436 nm. Flow rate was 0.5mlmin 1. An eluent mobile phase consisted of
24mM acetic acid:8% acetonitrile (pH 6.6) as solvent A and acetonitrile:2-propanol
(60:40) as solvent B. The gradient elution was used from 95% eluent A and 5%
eluent B to 25% eluent A and 75% eluent B for ﬁrst 15min. The column was
subsequently washed with 100% eluent B for 7min before the next sample injec-
tion. Norleucine (4mM) was used as internal standard. The volatile fatty acid
formation was measured on a Thermo Scientiﬁc Spectra HPLC system equipped
with an Agilent Metacarb 67H 300 6.5-mm column kept at 37 C and running
with 10mM arabinose as an eluent. The detector was a refractive index detector.
The eluent ﬂow was 0.8mlmin 1. Gas production was performed as previously
described46. All analyses were performed in duplicate. Ammonium was determined
using Spectroquant test kit according to the manufacture’s instruction.
Fructoselysine was separated by ion-exchange chromatography and quantiﬁed by
post column reaction with ninhydrin using photometric detection at 570 nm
(International Organization for Standardization (ISO) 13903).
Nuclear magnetic resonance. Strain AF211 was cultivated in a bicarbonate-
buffered medium containing 20mM of [2-13C]L-lysine or [6-13C]L-lysine or lysine
plus [2-13C]acetate. The growth conditions were as described above. 13C-labelled
lysine was purchased from Campro Scientiﬁc (Veenendaal, The Netherlands).
Samples were taken from an overnight culture and centrifuged at 10,000g. D2O
(50 ml; 99.9 atom%, Sigma Aldrich) was added to the supernatants (0.5ml) and
subsequently transferred in NMR tubes (Campro Scientiﬁc). 1H-decoupled 13C-
NMR spectra were recorded at a probe temperature of 300K on a Bruker Avance-
III-500 spectrometer located at the Wageningen NMR Centre (WNMRC),
Wageningen, the Netherlands. Chemical shifts are expressed in p.p.m. relative to
the C-6 of added [6-13C]lysine at 41.75 p.p.m., added [2-13C]lysine at 57.19 p.p.m.,
formed [2-13C]butyrate at 42.33 p.p.m., formed [4-13C]butyrate at 15.95 p.p.m. and
formed [2-13C]acetate at 25.99 p.p.m. (Biological Magnetic Resonance Data Bank,
http://www.bmrb.wisc.edu/metabolomics/metabolomics_standards). For the
HBMC spectra 400 experiments of 8 scans were recorded resulting in a measuring
time of 50min, using a standard Bruker pulse sequence. The products were
identiﬁed based on chemical shifts as compared with database as mentioned above.
In the HMBC experiment no decoupling is used (Fig. 3b). Therefore, the
single-bond couplings will result in double cross-peak split by the large single-bond
coupling. The active coupling between 5 and 10Hz of two- and three-bond
couplings remains within the width of a cross-peak in a HMBC spectrum, resulting
in single cross-peaks. When the carbon attached to the proton involved in a
three-bond coupling is also enriched, this cross-peak will be split by the large
single-bond coupling with this carbon. These splittings are visible as extra peaks
next to the single cross-peaks between H-2 and C-4 and between H-4 and C-2
(arrows in the ﬁgures), indicating double enrichment of both C-2 and C-4. The
calculation was shown in Fig. 3c. Both the split and non-split HMBC cross-peaks
with C-4 at H-2 and with C-2 at H-4 were integrated. The integrals of the split and
non-split cross-peaks at a single proton are comparable, since they are based on the
same three-bond couplings and experience similar relaxation behaviour. The split
cross-peaks of H-2 with C-4 and of H-4 with C-2 show a small difference due to
sensitivity of the HMBC experiment for difference in relaxation and difference
in coupling values. Since these split cross-peaks refer to the same population of
[2,4-13C]butyrate, the factor needed to equalize them can also be used to correct
the value of the non-split values, thus revealing the percentages of all three possible
fractions of labelled butyrate.
Proteomics. The protein abundances in cultures growing with different substrates
were investigated with liquid chromatography–mass spectrometry/mass spectro-
metry. Strain AF211 was grown in triplicate in 500ml bicarbonate-buffered
medium containing with 20mM lysine and 40mM glucose plus 40mM sodium
acetate as carbon and energy sources. Yeast extract was supplemented in the
culture of glucose plus acetate (2 g l 1). Cells were collected in the exponential
phase by centrifugation at 10,000g at 4 C for 20min. Cell pellets were washed
twice in 100mM Tris-HCl (pH 7.5), 1mM dithioerythreitol and suspended in 1ml
of SDT-lysis buffer, which contained 100mM Tris-HCl (pH 7.5), 4% SDS and
0.1M dithiotreitol. Protein extractions, separation, tryptic digestion and analysis
were performed as described previously47. An Intestinimonas AF211 database
downloaded from Uniprot (http://www.uniprot.org) was used together with a
contaminant database that contains sequences of common contaminants; for
instance, trypsin, keratin, bovine serum albumin. The proteomics result contained
peptides and proteins with a false discovery rate ofo1% and proteins with at least
two identiﬁed peptides of which should be unique and one should be unmodiﬁed
without any reversed hits. The normal logarithm was taken from protein label-free
quantitation (LFQ; normalized with respect to the total amount of protein and all
of its identiﬁed peptides) intensities. Zero ‘Log LFQ’ values were replaced by a
value of 5.4 (just below the lowest value) to make sensible ratio calculations
possible. Relative protein quantitation of sample to control was done with Perseus
1.3.0.4 by applying a two sample t-test using the ‘LFQ intensity’ columns obtained
with false discovery rate set to 0.05 and S0 set to 1.
Preparation of Intestinimonas AF211 cell extract. Strain AF211 was grown in
150ml anaerobic bicarbonate-buffered medium containing 20mM lysine or
40mM glucose plus 40mM acetate as carbon and energy sources. Cells of strain
A. rhamnosivorans DSM26241 (ref. 34) grown in 150ml anaerobic bicarbonate-
buffered medium containing 20mM glucose were used as a negative control of the
enzyme assay. Cells were collected in the exponential phase by centrifugation at
10,000g at 4 C for 20min. Cell pellets were washed twice in an anaerobic buffer
containing 100mM Tris-HCl (pH7.5), 1mM dithioerythreitol and suspended in
1ml of the same buffer. Cells were disrupted by sonication 5 times 30 s and the
cell suspension was cooled on ice for 30 s in between. Finally, the suspension was
centrifuged for 10min at 8,000g. The cell-free extract was transferred to serum
bottles, ﬂushed with N2 and either stored at  20 C or used directly for enzyme
activity assays. All steps were performed in an anaerobic chamber with a N2/H2
(96:4; v/v) atmosphere, circulated over a palladium catalyst to eliminate traces of
oxygen.
Detection of acetoacetyl-CoA transferase activity. CoA transferase activity was
determined using a spectrophotometric assay19 at 310 nm, 25 C with 100mM
Tris-Cl (pH 8.1), 20mM MgCl2 and 50 mM butyryl-CoA plus 10mM lithium
acetoacetate as substrates. For enzyme activity assay the formation of acetoacetyl-
CoA (E310nm¼ 15.1mM 1 cm 1) from butyryl-CoA and acetoacetate was
followed by measuring the increase in A310nm by means of an absorbance-recording
spectrophotometer. Total volume of the mixture was 1.0ml. The activities were
expressed as Umg 1 of total proteins (U¼mmolmin 1). All assays were done
with biological duplicates and 4–6 replicate measurements were performed. Total
protein was quantiﬁed using Qubit2.0 Fluorometer (Invitrogen) according to the
manufacturer’s instructions.
Phylogenetic analysis of CoA transferase. For the construction of a CoA
transferase phylogenetic tree, all butyryl-CoA:acetate CoA transferases (Ato) and
butyryl-CoA:4-hydroxybutyrate CoA transferases (4Hbt) from known intestinal
butyrate-producing bacteria according to refs. 28,48 were retrieved from the NCBI
database (Fig. 4). Selected 4-hydroxybutyrate CoA transferases from Clostridium
kluyveri, C. acetobutyricum and C. tetani were also included28. Butyryl-CoA-
acetoacetate CoA tranferases (Ato) from C. sticklandii DSM519, F. nucleatum
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ATCC25586 and C. acetobutylicum ATCC824 were collected from their
genomes29,33,49. These CoA transferases are catalysing either butyrate or butanol
formation. All amino-acid sequences of 4Hbt and AtoA/C/D from strain
Intestinimonas AF211 were aligned with retrieved sequences using the
CLUSTAL_X programme. A phylogenetic tree was constructed using the
neighbour-joining algorithm by the MEGA 5 with 1,000 bootstraps to obtain
conﬁdence levels for the branches.
Quantiﬁcation of Intestinimonas in the human colon. Stool samples of 10 Dutch
healthy volunteers at different age and gender were collected (Supplementary
Table 3). Genomic DNA was isolated via the bead-beating protocol described
previously50. The 16S rRNA sequences of phylogenetically related species were
retrieved from GenBank (www.ncbi.nlm.nih.gov) and used to perform multiple
alignments by using CLUSTALW. Primers for qPCR were designed using
DNASTAR programme according to Walter et al.51 Primers were PFF590f:
50-AAAACTATGGGCTCAACCCA-30 and PFF702r: 50-GTCAGTTAAT
GTCCAGCAGG-30 to quantify Intestinimonas AF211, which resulted in a 100-bp
amplicon. Total bacteria were quantiﬁed using BAC1396F and PROK1492R primer
pairs52. The 16S rRNA gene of strain AF211 was used for optimizing temperature
and primer concentration, and for making standard curves. The programme that
was used to amplify the partial 16S rRNA gene of strain AF211 was as following:
95 C for 5min and 35 cycles consisting of 95 C for 30 s, 56.7 C for 10 s and 72 C
for 30 s; 95 C for 1min and 60 C for 1min and total bacteria as followed: 95 C
for 10min or 95 C for 20 s, 56.3 C for 30 s and 72 C for 30 s; 95 C for 1min
and 60 C for 1min. Both were followed by a melting curve analysis. DNA
copies were calculated from standard curves and subsequently used for the
strain quantities.
Metagenome analysis. The metagenomic protein sequence data from faecal
samples of 65 Human Microbiome Project subjects were obtained from MG-RAST
(http://metagenomics.anl.gov/). The following samples were included: SRR063550,
SRR063552, SRR063553, SRR063555, SRR063556, SRR063558, SRR063561,
SRR063562, SRR063564, SRR063565, SRR061730, SRR063567, SRR063568,
SRR063570, SRR063571, SRR063573, SRR063574, SRR063576, SRR063577,
SRR063579, SRR063580, SRR063538, SRR063582, SRR063585, SRR063586,
SRR063588, SRR063589, SRR063802, SRR063899, SRR063900, SRR063902,
SRR063903, SRR063540, SRR063905, SRR063906, SRR063908, SRR063909,
SRR063539, SRR063542, SRR063545, SRR063548, SRR063551, SRR063554,
SRR063541, SRR063557, SRR063560, SRR063563, SRR063566, SRR063569,
SRR063572, SRR063575, SRR063578, SRR063581, SRR063584, SRR063543,
SRR063587, SRR063801, SRR063898, SRR063901, SRR063904, SRR063907,
SRR063544, SRR063546, SRR063547 and SRR063549.
AF211 butyrogenic pathway protein homologues were searched from the
metagenomic data by using Usearch v. 8.0.1517 with settings usearch_global
and id¼ 0.6. The results were analysed in R v. 3.1.1 software environment
(http://www.R-project.org)53.
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